/term/growth-per-share-ebitda/OSTO:EPIS%20B Episurf Medical AB (OSTO:EPIS B) YoY EBITDA Growth
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Episurf Medical AB (OSTO:EPIS B) » Definitions » YoY EBITDA Growth

Episurf Medical AB (OSTO:EPIS B) YoY EBITDA Growth : 14.75% (As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Episurf Medical AB YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Episurf Medical AB's YoY EBITDA Growth for the quarter that ended in Mar. 2024 was 14.75%.

Episurf Medical AB's EBITDA per Share for the three months ended in Mar. 2024 was kr-0.05.


Episurf Medical AB YoY EBITDA Growth Historical Data

The historical data trend for Episurf Medical AB's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Episurf Medical AB YoY EBITDA Growth Chart

Episurf Medical AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 40.97 62.46 20.75 4.76 -23.00

Episurf Medical AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -45.24 -58.00 -16.28 14.06 14.75

Episurf Medical AB YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Episurf Medical AB's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (A: Dec. 2023 )
=(EBITDA per Share (A: Dec. 2023 )-EBITDA per Share (A: Dec. 2022 ))/ | EBITDA per Share (A: Dec. 2022 ) |
=(-0.246--0.2)/ | -0.2 |
=-23.00 %

Episurf Medical AB's YoY EBITDA Growth for the quarter that ended in Mar. 2024 is calculated as:

YoY EBITDA Growth (Q: Mar. 2024 )
=(EBITDA per Share (Q: Mar. 2024 )-EBITDA per Share (Q: Mar. 2023 )) / | EBITDA per Share (Q: Mar. 2023 )) |
=(-0.052--0.061)/ | -0.061 |
=14.75 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Episurf Medical AB YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Episurf Medical AB's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Episurf Medical AB (OSTO:EPIS B) Business Description

Traded in Other Exchanges
Address
Karlavagen 60, Stockholm, SWE, 114 49
Episurf Medical AB is a medical device company. The company develops, manufactures, and commercializes solutions for the repair of the local cartilage damage in human joints. Its first patient-specific product portfolio, the knee portfolio, consists of the existing products Episealer Condyle Solo and Episealer Trochlea Solo, Episealer Femoral Twin, Epiguide MOS, and Epioscopy.

Episurf Medical AB (OSTO:EPIS B) Headlines

No Headlines